Authors’ Disclosures
ONCOLOGY, BANG
J. Tabernero reports personal fees from Array Biopharma, AstraZeneca, Bayer, Boehringer Ingelheim, Cardiff Oncology, Chugai, Daiichi Sankyo, F. Hoffmann-La Roche Ltd, Genentech Inc, HalioDX SAS, Hutchison MediPharma International, Ikena Oncology, Inspirna Inc, IQVIA, Lilly, Menarini, Merck Serono, Merus, MSD, Mirati, Neophore, Novartis, Ona Therapeutics, Orion Biotechnology, Peptomyc, Pfizer, Pierre Fabre, Samsung Bioepis, Sanofi, Scandion Oncology, Scorpion Therapeutics, Seattle Genetics, Servier, Sotio Biotech, Taiho, Tessa Therapeutics, TheraMyc and Tolremo Therapeutics, Imedex/HMP, Medscape Education, MJH Life Sciences, PeerView Institute for Medical Education and Physicians Education Resource (PER), and other from Oniria Therapeutics outside the submitted work. P.L. Bedard reports grants from Sanofi during the conduct of the study; grants from BMS, Genentech/Roche, AstraZeneca, GlaxoSmithKline, Novartis, Seagen, Lilly, Amgen, Nektar, Zymeworks, Bicara Therapeutics, Medicenna, and Immunomedics outside the submitted work; and uncompensated advisory from: Gilead, Zymeworks, Seagen, Lilly, Merck, Pfizer, BMS. Y.-J. Bang reports grants from Sanofi during the conduct of the study; personal fees from Astellas, Amgen, Samyang Biopharm, Hanmi, Daewoong, SK Biopharm outside the submitted work. M. Vieito reports personal fees from BMS and grants from ROCHE outside the submitted work; and principal investigator in clinical trials for ROCHE, BMS, Debiopharm, Enterome, Novartis, Hutchinson Pharma, Incyte, Laminar Pharma. M.-H. Ryu reports personal fees from BMS, ONO, MSD, Astellas, Daiichi-Sankyo, Sanofi, and Taiho; grants and personal fees from AstraZeneca outside the submitted work. N. Fagniez is an employee of Sanofi. M. Chadjaa reports other from Sanofi during the conduct of the study. C. Soufflet reports other from Sanofi during the conduct of the study; other from Sanofi outside the submitted work. N. Masson reports other from IT&M Stats (my company) outside the submitted work. No other disclosures were reported.